BRIEF-Tonix Pharmaceuticals Holding Corp - Discontinued Enrollment And Terminated Phase 2 Catalyst Study - SEC Filing

Reuters
26 Apr
BRIEF-Tonix Pharmaceuticals Holding Corp - Discontinued Enrollment And Terminated Phase 2 Catalyst Study - SEC Filing

April 25 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:

  • TONIX PHARMACEUTICALS HOLDING CORP - DISCONTINUED ENROLLMENT AND TERMINATED PHASE 2 CATALYST STUDY - SEC FILING

  • TONIX PHARMACEUTICALS - EVALUATING NEW STUDY DESIGNS AND NEW ENDPOINTS FOR FURTHER DEVELOPMENT OF TNX-1300

Source text: [ID:n0001999371-25-004807]

Further company coverage: TNXP.O

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10